. 2016 Apr 29;14:108. doi: 10.1186/s12967-016-0856-2

Table 3.

Correlations of the expression of miR-7, miR-93, miR-141, miR-195, miR-494, and let-7b with the clinicopathologic characteristics of 104 patients with UICC¹ stage II–III colorectal cancer

Variables	miR-7		miR-93		miR-141		miR-195		miR-494		let-7b
Variables	Number mean ± SD	P value	Number mean ± SD	P value	Number mean ± SD	P value	Number mean ± SD	P value	Number mean ± SD	P value	Number mean ± SD	P value
Sex	61/38	0.900	64/40	0.193	64/39	0.832	63/40	0.235	63/40	0.483	57/38	0.401
Male	−0.66 ± 0.73		1.70 ± 0.66		0.18 ± 0.68		0.41 ± 0.47		1.98 ± 1.18		2.40 ± 0.65
Female	−0.68 ± 0.70		1.54 ± 0.62		0.21 ± 0.75		0.28 ± 0.63		2.15 ± 1.23		2.27 ± 0.73
Age	60/39	0.427	62/42	0.266	62/41	0.663	62/41	0.074	62/41	0.651	55/40	0.005
≥65 years	−0.71 ± 0.69		1.59 ± 0.70		0.17 ± 0.68		0.29 ± 0.57		2.00 ± 1.28		2.19 ± 0.68
<65 years	−0.60 ± 0.76		1.72 ± 0.55		0.23 ± 0.47		0.47 ± 0.47		2.11 ± 1.28		2.57 ± 0.62
UICC Stage	51/48	0.053	54/50	0.029	54/49	0.954	50/53	0.056	49/54	0.032	46/49	0.419
II	−0.53 ± 0.69		1.77 ± 0.66		0.19 ± 0.72		0.46 ± 0.57		2.28 ± 1.20		2.40 ± 0.70
III	−0.81 ± 0.72		1.50 ± 0.61		0.20 ± 0.69		0.26 ± 0.48		1.88 ± 1.14		2.29 ± 0.70
Maximum size	48/51	0.500	51/53	0.856	50/53	0.407	50/53	0.234	50/53	0.400	49/46	0.854
≥5 cm	−0.62 ± 0.74		1.63 ± 0.58		0.13 ± 0.72		0.29 ± 0.59		1.94 ± 1.24		2.34 ± 0.65
<5 cm	−0.72 ± 0.70		1.65 ± 0.71		0.25 ± 0.69		0.42 ± 0.48		2.14 ± 1.15		2.36 ± 0.72
Location	71/28	0.311	76/28	0.075	75/28	0.023	28/75	0.345	27/76	0.001	27/68	0.602
Colon	−0.72 ± 0.72		1.71 ± 0.65		0.09 ± 0.69		0.39 ± 0.57		1.81 ± 1.14		2.37 ± 0.73
Rectum	−0.55 ± 0.70		1.46 ± 0.61		0.49 ± 0.68		0.29 ± 0.45		2.69 ± 1.12		2.30 ± 0.56
Vascular invasion	27/72	0.961	28/76	0.117	27/76	0.497	28/75	0.084	28/75	0.881	25/70	0.072
Yes	−0.68 ± 0.78		1.48 ± 0.60		0.28 ± 0.77		0.21 ± 0.53		2.01 ± 1.22		2.16 ± 0.54
No	−0.67 ± 0.70		1.70 ± 0.66		0.16 ± 0.68		0.42 ± 0.53		2.05 ± 1.20		2.42 ± 0.72
Perineural invasion	26/73	0.006	27/77	0.375	26/77	0.226	27/76	0.457	27/76	0.134	24/71	0.534
Yes	−0.34 ± 0.67		1.55 ± 0.60		0.36 ± 0.84		0.29 ± 0.59		2.35 ± 1.21		2.26 ± 0.82
No	−0.79 ± 0.70		1.67 ± 0.66		0.13 ± 0.65		0.38 ± 0.52		1.94 ± 1.18		2.38 ± 0.82
Lymph node metastasis	51/48	0.053	54/50	0.029	54/49	0.954	50/53	0.056	49/54	0.032	46/49	0.419
No	−0.53 ± 0.69		1.77 ± 0.66		0.19 ± 0.72		0.46 ± 0.57		2.28 ± 1.20		2.40 ± 0.70
Yes	−0.81 ± 0.72		1.50 ± 0.61		0.20 ± 0.69		0.26 ± 0.48		1.88 ± 1.14		2.29 ± 0.70
Type	89/10	0.440	94/10	0.350	93/10	0.754	93/10	0.480	94/9	0.627	86/9	0.122
Adenocarcinoma	−0.65 ± 0.72		1.66 ± 0.64		0.18 ± 0.72		0.35 ± 0.54		2.03 ± 1.22		2.39 ± 0.67
Mucinous carcinoma	−0.83 ± 0.67		1.44 ± 0.71		0.25 ± 0.58		0.47 ± 0.50		2.20 ± 0.96		1.98 ± 0.68